These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9781507)

  • 21. Diagnosing paratonia in the demented elderly: reliability and validity of the Paratonia Assessment Instrument (PAI).
    Hobbelen JS; Koopmans RT; Verhey FR; Habraken KM; de Bie RA
    Int Psychogeriatr; 2008 Aug; 20(4):840-52. PubMed ID: 18177542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paratonia, Gegenhalten and psychomotor hypertonia Back to the roots.
    Foucher JR; Dormegny-Jeanjean LC; Bartsch AJ; Humbert I; de Billy CC; Obrecht A; Mainberger O; Clauss JME; Waddington JL; Wolf RC; Hirjak D; Morra C; Ungvari G; Schorr B; Berna F; Shorter E
    Schizophr Res; 2024 Jan; 263():35-44. PubMed ID: 36155159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced Glycation End-Products Are Associated With the Presence and Severity of Paratonia in Early Stage Alzheimer Disease.
    Drenth H; Zuidema SU; Krijnen WP; Bautmans I; van der Schans C; Hobbelen H
    J Am Med Dir Assoc; 2017 Jul; 18(7):636.e7-636.e12. PubMed ID: 28558966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Applause sign" helps to discriminate PSP from FTD and PD.
    Dubois B; Slachevsky A; Pillon B; Beato R; Villalponda JM; Litvan I
    Neurology; 2005 Jun; 64(12):2132-3. PubMed ID: 15985587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Depression and frontal dysfunction: risks for the elderly?].
    Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
    Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypergraphia and brain damage.
    Frisoni GB; Scuratti A; Bianchetti A; Trabucchi M
    J Neurol Neurosurg Psychiatry; 1993 May; 56(5):576-7. PubMed ID: 8505657
    [No Abstract]   [Full Text] [Related]  

  • 27. Precis of executive dyscontrol as a cause of problem behavior in dementia.
    Royall DR
    Exp Aging Res; 1994; 20(2):73-94. PubMed ID: 8020543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Movement dysfunction following central nervous system lesions: a problem of neurologic or muscular impairment?
    Carey JR; Burghardt TP
    Phys Ther; 1993 Aug; 73(8):538-47. PubMed ID: 8337241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The seizures of frontal lobe epilepsy. A study of clinical manifestations.
    Geier S; Bancaud J; Talairach J; Bonis A; Szikla G; Enjelvin M
    Neurology; 1977 Oct; 27(10):951-8. PubMed ID: 561909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frontal lobe dysfunction in sporadic hyperekplexia--case study and literature review.
    Gaitatzis A; Kartsounis LD; Gacinovic S; Costa DC; Harvey K; Harvey RJ; de Silva RN
    J Neurol; 2004 Jan; 251(1):91-8. PubMed ID: 14999495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progressive frontal dysfunction.
    Benson DF
    Dementia; 1993; 4(3-4):149-53. PubMed ID: 8401783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychotic symptoms in dementia associated with motor neuron disease: a pathophysiological hypothesis.
    Nitrini R; Rosemberg S
    J Neuropsychiatry Clin Neurosci; 1998; 10(4):456-8. PubMed ID: 9813793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Passive movement therapy in severe paratonia: a multicenter randomized clinical trial.
    Hobbelen JH; Tan FE; Verhey FR; Koopmans RT; de Bie RA
    Int Psychogeriatr; 2012 May; 24(5):834-44. PubMed ID: 22185768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The "non-Alzheimer" degenerative dementias.
    Salmon E
    Acta Neurol Belg; 1994; 94(4):227-30. PubMed ID: 7839798
    [No Abstract]   [Full Text] [Related]  

  • 35. [Frontal lobe dysfunction in ALS].
    Alcaz S; Apostolski S
    Srp Arh Celok Lek; 1995; 123(9-10):266-70. PubMed ID: 17974446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associative learning impairments in patients with frontal lobe damage.
    Dimitrov M; Granetz J; Peterson M; Hollnagel C; Alexander G; Grafman J
    Brain Cogn; 1999 Nov; 41(2):213-30. PubMed ID: 10590820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Saccade impairments in patients with fronto-temporal dementia.
    Meyniel C; Rivaud-Péchoux S; Damier P; Gaymard B
    J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1581-4. PubMed ID: 16227556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Many faces of dementia on a neurology inpatient unit.
    Ramchandani D; Schindler B; Matthews M; Podell K
    Psychosomatics; 1994; 35(4):395-9. PubMed ID: 8084990
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence, incidence and risk factors of paratonia in patients with dementia: a one-year follow-up study.
    Hobbelen JS; Tan FE; Verhey FR; Koopmans RT; de Bie RA
    Int Psychogeriatr; 2011 Sep; 23(7):1051-60. PubMed ID: 21269542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fahr's disease: clinical picture and treatment approaches].
    Ponomarev VV; Naumenko DV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(3):62-4. PubMed ID: 15071847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.